Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization

PLoS Pathogens - Tập 4 Số 9 - Trang e1000159
Ying‐Jie Lu1, Jane A. Gross1, Debby Bogaert2,1, Adam Finn3, Linda Bagrade3, Qibo Zhang3, Jay K. Kolls4, Amit Srivastava1, Anna Lundgren5, Sophie Forte1, Claudette M. Thompson2, Kathleen F. Harney6, Porter Anderson1, Marc Lipsitch2, Richard Malley1
1Division of Infectious Diseases, Department of Medicine, Children's Hospital, and Harvard Medical School, Boston, Massachusetts, United States of America
2Departments of Epidemiology and Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America
3Departments of Clinical Sciences at South Bristol, Academic Unit of Child Health, and of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
4Division of Pulmonology, Department of Pediatrics, Children's Hospital of Pittsburgh and the University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
5Göteborg University Vaccine Research Institute (GUVAX), Department of Microbiology and Immunology, Institute of Biomedicine, Göteborg University, Sweden
6Department of Obstetrics and Gynecology, Cambridge Health Alliance, Cambridge, Massachusetts, United States of America

Tóm tắt

Từ khóa


Tài liệu tham khảo

F Lord, 1938, Pneumonia and Serum Therapy, 10.1097/00000441-193808000-00036

S Black, 2000, Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group [In Process Citation]., Pediatr Infect Dis J, 19, 187, 10.1097/00006454-200003000-00003

R Dagan, 2002, Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers., J Infect Dis, 185, 927, 10.1086/339525

D Goldblatt, 2005, Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study., J Infect Dis, 192, 387, 10.1086/431524

DM Weinberger, 2008, Epidemiologic Evidence for Serotype-Specific Acquired Immunity to Pneumococcal Carriage., J Infect Dis, 197, 1511, 10.1086/587941

M Lipsitch, 2005, Age-specific incidence of invasive pneumococcal disease by serotype: Are anticapsular antibodies the primary mechanism of protection against invasive disease?, PLoS Med, 2, e15, 10.1371/journal.pmed.0020015

L Hogberg, 2007, Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci., J Clin Microbiol, 45, 948, 10.1128/JCM.01913-06

R Dagan, 2004, Changing the Ecology of Pneumococci with Antibiotics and Vaccines., 283

TL McCool, 2003, Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization., Infect Immun, 71, 5724, 10.1128/IAI.71.10.5724-5732.2003

TL McCool, 2004, Limited Role of Antibody in Clearance of Streptococcus pneumoniae in a Murine Model of Colonization., Infect Immun, 72, 5807, 10.1128/IAI.72.10.5807-5813.2004

R Malley, 2007, Serum antipneumococcal antibodies and pneumococcal colonization in adults with chronic obstructive pulmonary disease., J Infect Dis, 196, 928, 10.1086/520937

DE Briles, 2003, Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae., J Infect Dis, 188, 339, 10.1086/376571

AD Ogunniyi, 2000, Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae., Infect Immun, 68, 3028, 10.1128/IAI.68.5.3028-3033.2000

DE Briles, 2000, The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection., Vaccine, 18, 1707, 10.1016/S0264-410X(99)00511-3

B Simell, 2006, Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media., Clin Vaccine Immunol, 13, 1177, 10.1128/CVI.00257-06

S Rapola, 2003, Anti-PsaA and the risk of pneumococcal AOM and carriage., Vaccine, 21, 3608, 10.1016/S0264-410X(03)00409-2

B Simell, 2001, Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children., J Infect Dis, 183, 887, 10.1086/319246

K Trzcinski, 2005, Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model., Infect Immun, 73, 7043, 10.1128/IAI.73.10.7043-7046.2005

R Malley, 2005, CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization., Proc Natl Acad Sci U S A, 102, 4848, 10.1073/pnas.0501254102

AM van Rossum, 2005, Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model., Infect Immun, 73, 7718, 10.1128/IAI.73.11.7718-7726.2005

R Malley, 2006, Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide., Infect Immun, 74, 2187, 10.1128/IAI.74.4.2187-2195.2006

A Basset, 2007, Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins., Infect Immun, 75, 5460, 10.1128/IAI.00773-07

JK Kolls, 2004, Interleukin-17 family members and inflammation., Immunity, 21, 467, 10.1016/j.immuni.2004.08.018

Q Zhang, 2007, Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children., J Infect Dis, 195, 1194, 10.1086/512617

S Rapola, 2000, Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media., J Infect Dis, 182, 1146, 10.1086/315822

C Laine, 2004, Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya., Infect Immun, 72, 3331, 10.1128/IAI.72.6.3331-3335.2004

GR Siber, 1992, Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease., J Infect Dis, 165, S129, 10.1093/infdis/165-Supplement_1-S129

DR Hoover, 1993, Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study., N Engl J Med, 329, 1922, 10.1056/NEJM199312233292604

J Phair, 1990, The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group., N Engl J Med, 322, 161, 10.1056/NEJM199001183220304

CF Gilks, 1996, Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya., Lancet, 347, 718, 10.1016/S0140-6736(96)90076-8

MS Dworkin, 2001, Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination., Clin Infect Dis, 32, 794, 10.1086/319218

CJ Gill, 2008, Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women., J Infect Dis, 197, 1000, 10.1086/528806

H Takahashi, 2003, Decreased serum opsonic activity against Streptococcus pneumoniae in human immunodeficiency virus-infected Ugandan adults., Clin Infect Dis, 37, 1534, 10.1086/379511

K Titanji, 2006, Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection., Blood, 108, 1580, 10.1182/blood-2005-11-013383

SB Gordon, 2005, HIV-1 infection is associated with altered innate pulmonary immunity., J Infect Dis, 192, 1412, 10.1086/462428

BM Gray, 1988, Epidemiological studies of Streptococcus pneumoniae in infants: antibody to types 3, 6, 14, and 23 in the first two years of life., Journal of Infectious Diseases, 158, 948, 10.1093/infdis/158.5.948

DM Musher, 1997, Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization., Clinical Infectious Diseases, 24, 441, 10.1093/clinids/24.3.441

R Dagan, 2005, Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus., J Infect Dis, 192, 367, 10.1086/431679

TL McCool, 2002, The immune response to pneumococcal proteins during experimental human carriage., J Exp Med, 195, 359, 10.1084/jem.20011576

K Trzcinski, 2008, Protection against Nasopharyngeal Colonization by Streptococcus pneumoniae is Mediated by Antigen-Specific CD4+ T Cells., Infect Immun

M Veldhoen, 2006, TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells., Immunity, 24, 179, 10.1016/j.immuni.2006.01.001

E Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells., Nature, 441, 235, 10.1038/nature04753

P Ye, 2001, Interleukin-17 and lung host defense against Klebsiella pneumoniae infection., Am J Respir Cell Mol Biol, 25, 335, 10.1165/ajrcmb.25.3.4424

W Huang, 2004, Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice., J Infect Dis, 190, 624, 10.1086/422329

SC Higgins, 2006, TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells., J Immunol, 177, 7980, 10.4049/jimmunol.177.11.7980

SA Khader, 2005, IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available., J Immunol, 175, 788, 10.4049/jimmunol.175.2.788

SA Khader, 2007, IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge., Nat Immunol, 8, 369, 10.1038/ni1449

B Simell, 2007, Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media., J Infect Dis, 196, 1528, 10.1086/522607

R Malley, 2001, Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci., Infect Immun, 69, 4870, 10.1128/IAI.69.8.4870-4873.2001

P Ye, 2001, Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense., J Exp Med, 194, 519, 10.1084/jem.194.4.519

HY Wu, 1997, Nasal lymphoid tissue (NALT) as a mucosal immune inductive site., Scand J Immunol, 46, 506, 10.1046/j.1365-3083.1997.d01-159.x

MR Smith, 1958, Surface phagocytosis; further evidence of its destructive action upon fully encapsulated pneumococci in the absence of type-specific antibody., J Exp Med, 107, 1, 10.1084/jem.107.1.1

Q Zhang, 2004, Mucosal immune responses to capsular pneumococcal polysaccharides in immunized preschool children and controls with similar nasal pneumococcal colonization rates., Pediatr Infect Dis J, 23, 307, 10.1097/00006454-200404000-00006

Q Zhang, 2006, Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status., Eur J Immunol, 36, 46, 10.1002/eji.200535101

T Robertson, 1988, Order Restricted Statistical Inference